Claritin Syrup (loratadine)
Company: Schering-Plough
Approval Status: Approved October 1996
Treatment for: seasonal allergies in children
Areas: Pediatrics/Neonatology; Pulmonary/Respiratory Diseases
Possible similar drugs: Claritin RediTabs
| General Information | Clinical Results |
General Information
Claritin Syrup has been approved as a non-drowsy antihistamine syrup for children as young as six years of age. In addition, the indication for Claritin tablets was expanded to include children age six years and up.
Available only by prescription in a once-daily formula, Claritin Syrup is indicated for the treatment of allergy symptoms, including itchy, watery eyes; runny nose; itchy palate; sneezing; and idiopathic chronic urticaria (hives).
Claritin Syrup, in an alcohol-free and dye-free fruit flavored formula, is administered orally at a dose of two teaspoons once-per-day for children as young as six years of age.
Clinical Results
In controlled clinical trials using the recommended dose, the incidence of the most commonly reported adverse events was comparable to placebo.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
